Biocytogen: Funding, Investors & Team (Sep 2026)
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).
Biocytogen has raised $970M across 1 funding round on record, the most recent an undisclosed round of $970M announced in Sep 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biocytogen Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Biocytogen Funding Rounds
Biocytogen Founders and Leadership Team
Contact details for the Biocytogen team: 1 of 1 has an email address on file.
Start 14-day free trial →Biocytogen Funding Compared to Other Biotechnology Startups
Biocytogen's latest round of $970M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biocytogen in Biotechnology and Worcester
Companies Similar to Biocytogen
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Biocytogen Funding FAQs
What does Biocytogen do?
Biocytogenan advanced biotechnology company located in Beijing's Economic and Technological Development Zone, was founded in November 2009 by a team of scientists who have multiple years’ experience developing animal models and operating Biocytogen USA. Biocytogen's goal is to become the leading gene targeted animal model and service supplier globally. Biocytogen efficiently integrates the advanced capabilities and resources available in both China and the USA. Biocytogen has established two excellent gene-targeting platforms. The first is a traditional ESC/HR platform that includes a unique gene targeting vector construction technology with an accurate micro-injection system and high germline transmission efficiency of C57BL/6 mouse embryonic stem cells (ESC).
How much funding has Biocytogen raised?
Biocytogen has raised $970M across 1 round on record. The most recent is an undisclosed round of $970M announced in Sep 2020.
When did Biocytogen last raise funding?
Biocytogen's most recent funding round on record is an undisclosed round of $970M, announced in Sep 2020.
Who is the CEO of Biocytogen?
Yuelei Shen is listed as CEO at Biocytogen.
Where is Biocytogen headquartered?
Biocytogen is based in Worcester, Massachusetts, United States.
How many employees does Biocytogen have?
Biocytogen is in the 51-100 employee band.
How does Biocytogen's funding compare to other Biotechnology startups?
Biocytogen's latest round of $970M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Biocytogen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biocytogen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.